Eventide Asset Management, LLC reported 299 positions worth $7.45B for the quarter ended Jun 30, 2026, up 24.7% on the prior quarter. It opened 57 new positions, added to 161, trimmed 68 and exited 32. Its largest holding is Guardant Health, Inc. at 3.9% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| AVLN Avalyn Pharma Inc. | +1.38M | – | $45.28M | 0.608% |
| DELL Dell Technologies Inc. | +88.3K | +90.9% | $37.77M | 1.07% |
| CDNS Cadence Design Systems Inc | +84.4K | +425.0% | $31.64M | 0.525% |
| RELY Remitly Global, Inc. | +1.33M | – | $29.86M | 0.401% |
| FITB Fifth Third Bancorp | +499.6K | +1,266.0% | $28.23M | 0.409% |
| SNX Td Synnex Corp | +101.0K | – | $27.03M | 0.363% |
| DDOG Datadog, Inc. | +102.5K | +42.7% | $26.65M | 1.2% |
| ORKA Oruka Therapeutics, Inc. | +240.0K | – | $22.84M | 0.307% |
| CRDO Credo Technology Group Holding Ltd | +74.7K | +2,766.9% | $20.20M | 0.281% |
| MLM Martin Marietta Materials Inc | +34.5K | +1,185.6% | $19.90M | 0.29% |
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| XMTR Xometry, Inc. | -808.4K | -27.3% | $78.28M | 2.8% |
| GH Guardant Health, Inc. | -404.6K | -17.1% | $60.71M | 3.94% |
| PLD Prologis, Inc. | -427.1K | -100.0% | $56.06M | Exited |
| AXSM Axsome Therapeutics, Inc. | -202.7K | -39.0% | $49.62M | 1.04% |
| GLBE Global-E Online Ltd. | -1.22M | -100.0% | $37.56M | Exited |
| ROP Roper Technologies Inc | -91.4K | -95.6% | $30.84M | 0.019% |
| GEV GE Vernova Inc. | -26.2K | -19.7% | $30.52M | 1.67% |
| WCN Waste Connections, Inc. | -157.6K | -50.8% | $26.27M | 0.341% |
| EQT EQT Corp | -400.0K | -100.0% | $25.50M | Exited |
| ADCT ADC Therapeutics SA | -5.70M | -100.0% | $21.38M | Exited |
| Holding | Shares | Trade Value | Weight |
|---|---|---|---|
| AVLN Avalyn Pharma Inc. | +1.38M | $45.28M | 0.608% |
| RELY Remitly Global, Inc. | +1.33M | $29.86M | 0.401% |
| SNX Td Synnex Corp | +101.0K | $27.03M | 0.363% |
| ORKA Oruka Therapeutics, Inc. | +240.0K | $22.84M | 0.307% |
| SYRE Spyre Therapeutics, Inc. | +201.6K | $17.90M | 0.24% |
| BKH Black Hills Corp | +230.4K | $17.16M | 0.23% |
| NXPI NXP Semiconductors N.V. | +56.2K | $15.77M | 0.212% |
| ACHV Achieve Life Sciences, Inc. | +2.22M | $14.50M | 0.195% |
| KLRA Kailera Therapeutics, Inc. | +616.7K | $13.59M | 0.182% |
| TNGX Tango Therapeutics, Inc. | +400.0K | $12.50M | 0.168% |
| Holding | Shares Sold | Trade Value | Prior Weight |
|---|---|---|---|
| PLD Prologis, Inc. | -427.1K | $56.06M | 0.939% |
| GLBE Global-E Online Ltd. | -1.22M | $37.56M | 0.629% |
| EQT EQT Corp | -400.0K | $25.50M | 0.427% |
| ADCT ADC Therapeutics SA | -5.70M | $21.38M | 0.358% |
| IVVD Invivyd, Inc. | -9.07M | $11.79M | 0.197% |
| OCS Oculis Holding AG | -430.0K | $11.43M | 0.191% |
| CSTL Castle Biosciences Inc | -386.4K | $9.49M | 0.159% |
| CRVS Corvus Pharmaceuticals, Inc. | -550.0K | $8.05M | 0.135% |
| HELP Helus Pharma Inc. | -1.41M | $6.77M | 0.113% |
| EVH Evolent Health, Inc. | -2.55M | $5.81M | 0.097% |
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | GH Guardant Health, Inc. | Healthcare | 1.96M | $293.79M | 3.94% | -404.6K | -17.1% | Reduced | 1.47% |
| 2 | LRCX Lam Research Corp | Technology | 673.4K | $291.72M | 3.92% | -15.0K | -2.2% | Reduced | 0.05% |
| 3 | XMTR Xometry, Inc. | Technology | 2.15M | $208.36M | 2.8% | -808.4K | -27.3% | Reduced | 3.77% |
| 4 | TT Trane Technologies plc | Industrials | 415.0K | $203.49M | 2.73% | +8,484 | +2.1% | Added | 0.19% |
| 5 | MIRM Mirum Pharmaceuticals, Inc. | Healthcare | 1.25M | $146.20M | 1.96% | -160.5K | -11.4% | Reduced | 1.93% |
| 6 | ASML Asml Holding Nv | Technology | 68.4K | $136.00M | 1.83% | +300 | +0.4% | Added | 0.02% |
| 7 | TRGP Targa Resources Corp. | Energy | 490.7K | $131.75M | 1.77% | -11.6K | -2.3% | Reduced | 0.23% |
| 8 | ODFL Old Dominion Freight Line, Inc. | Industrials | 599.5K | $129.92M | 1.74% | +7,767 | +1.3% | Added | 0.29% |
| 9 | GEV GE Vernova Inc. | Industrials | 107.0K | $124.66M | 1.67% | -26.2K | -19.7% | Reduced | 0.04% |
| 10 | URI United Rentals, Inc. | Industrials | 103.4K | $117.16M | 1.57% | +5,650 | +5.8% | Added | 0.17% |
| 11 | ARGX Argenx Se | Healthcare | 125.7K | $116.58M | 1.56% | +11 | +0.0% | Added | 0.21% |
| 12 | SRRK Scholar Rock Holding Corp | Healthcare | 2.11M | $116.13M | 1.56% | -86.0K | -3.9% | Reduced | 1.62% |
| 13 | IRTC iRhythm Holdings, Inc. | Healthcare | 880.3K | $104.71M | 1.41% | +119.5K | +15.7% | Added | 2.67% |
| 14 | KLAC Kla Corp | Technology | 339.3K | $100.92M | 1.35% | -57.1K | -14.4% | Reduced | 0.03% |
| 15 | BBNX Beta Bionics, Inc. | Healthcare | 6.25M | $98.05M | 1.32% | +308.2K | +5.2% | Added | 14.04% |
Tip. Select a row to see that position’s full history at Eventide Asset Management.
As of its Q2 2026 13F filing, Eventide Asset Management, LLC’s five largest positions were Guardant Health, Inc. (GH) at 3.9%, Lam Research Corp (LRCX) at 3.9%, Xometry, Inc. (XMTR) at 2.8%, Trane Technologies plc (TT) at 2.7%, Mirum Pharmaceuticals, Inc. (MIRM) at 2.0% of the reported portfolio.
Eventide Asset Management, LLC reported a 13F portfolio worth $7.45B across 299 positions for Q2 2026. That is up 24.7% from the previous quarter.
Its largest purchases by value were Avalyn Pharma Inc. ($45.28M), Dell Technologies Inc. ($37.77M), Cadence Design Systems Inc ($31.64M). It opened 57 new positions.
Its largest sales by value were Xometry, Inc. ($78.28M), Guardant Health, Inc. ($60.71M), Prologis, Inc. ($56.06M). It exited 32 positions entirely.
From the Form 13F-HR reports Eventide Asset Management, LLC files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.